Pyrrolcarboxamide derivatives for the inhbition of erk5
Cancer Research Technology Ltd (2016) Pyrrolcarboxamide derivatives for the inhbition of erk5. PCT/GB2015/052707.
Item Type: | Patents |
---|
Abstract
The invention provides compounds of formula (I) or a tautomer, stereoisomer, N-oxide, pharmaceutically acceptable salt or solvate thereof. The compounds are useful for the prophylaxis or treatment of a disease state or condition mediated by ERK5 in particular cancers.
|
PDF (Pyrrolcarboxamide derivatives for the inhbition of erk5)
Patent_WO2016042341A1.pdf - Published Version Download (8MB) | Preview |
More Information
Depositing User: Stephanie Myers |
Identifiers
Item ID: 9286 |
Identification Number: PCT/GB2015/052707 |
URI: http://sure.sunderland.ac.uk/id/eprint/9286 | Official URL: https://patentscope.wipo.int/search/en/detail.jsf?... |
Users with ORCIDS
Catalogue record
Date Deposited: 10 May 2018 08:18 |
Last Modified: 18 Dec 2019 16:06 |
Author: | Stephanie Myers |
Inventor: | Tristan Reuillon |
Inventor: | Duncan Miller |
Inventor: | Stephanie Myers |
Inventor: | Lauren Molyneux |
Inventor: | Celine Cano |
Inventor: | Ian Hardcastle |
Inventor: | Roger Griffin |
Inventor: | Laurent Rigoreau |
Inventor: | Bernard Golding |
Inventor: | Martin Noble |
University Divisions
Faculty of Health Sciences and WellbeingFaculty of Health Sciences and Wellbeing > School of Pharmacy and Pharmaceutical Sciences
Subjects
Sciences > ChemistrySciences > Pharmacy and Pharmacology
Actions (login required)
View Item (Repository Staff Only) |